News | July 26, 2024
Laurus Labs posts Q1 FY25 consolidated PAT at Rs. 12.51 Cr
Laurus Labs has reported total income of Rs. 1,197.42 crores during the period ended June 30, 2024
Laurus Labs has reported total income of Rs. 1,197.42 crores during the period ended June 30, 2024
Thyrocare Technologies has reported total income of Rs. 160.53 crores during the period ended June 30, 2024
Torrent Pharmaceuticals has reported total income of Rs. 2,883 crores during the period ended June 30, 2024
Poly Medicure has reported total income of Rs. 401.69 crores during the period ended June 30, 2024
Solara Active Pharma Sciences has reported total income of Rs. 364.05 crores during the period ended June 30, 2024
The integrated company delivers a broad portfolio of over 30,000 lab products across microscopy, histology, and other research areas
Ephedrine Sulfate injection USP, 50 mg/mL is indicated for the treatment of clinically important hypotension
Susvimo is a unique therapeutic approach that provides continuous delivery of medicine to the eye through a refillable implant
The pooled prevalence of GERD in the Indian population is 15.6 %
Vimta Labs has reported total income of Rs. 82.44 crores during the period ended June 30, 2024
Subscribe To Our Newsletter & Stay Updated
